We are live on ! Find out more
GNPX icon

Genprex

15 hedge funds and large institutions have $153K invested in Genprex in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more capital invested

Capital invested by funds: $93.5K → $153K (+$59.4K)

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

7% more funds holding

Funds holding: 1415 (+1)

0% less ownership

Funds ownership: 0%0% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Raymond James Financial
26
Raymond James Financial
Florida
$1
HF
27
HRT Financial
New York
-$11K -42 Closed
CCM
28
Corsair Capital Management
New York
-$2.45K -9 Closed
IA
29
IFP Advisors
Florida
-$1.1K -4 Closed
Northwestern Mutual Wealth Management
30
Northwestern Mutual Wealth Management
Wisconsin
-$126

GNPX Hedge Fund Activity: Q2 2025 in Review

15 of the 7,603 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q2 2025, worth a combined $153K — up 63% from $93.5K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new GNPX positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $84.6K. The largest seller was HighTower Advisors, cutting an estimated $18K.

  • 15 institutional investors held Genprex (GNPX) as of Q2 2025, up from 14 in Q1 2025.
  • Funds reported $153K of Genprex stock for Q2 2025, up 63% quarter-over-quarter.
  • 4 funds opened new Genprex positions in Q2 2025 and 3 closed out, a net change of +1 holder.
  • The largest Genprex buyer in Q2 2025 was Susquehanna International Group, an estimated $84.6K added.
  • The largest Genprex seller in Q2 2025 was HighTower Advisors, an estimated $18K sold.

Based on aggregated 13F filings for Q2 2025.